Attached files

file filename
EX-31.1 - EX-31.1 - JUNIPER PHARMACEUTICALS INCjnp-ex311_7.htm
10-K/A - 10-K/A - JUNIPER PHARMACEUTICALS INCjnp-10ka_20161231.htm

 

Exhibit 31.2

Certification Pursuant to Rule 13a-14(a)/15d-14(a)

of the Securities Exchange Act of 1934

I, Jeffrey E. Young, certify that:

1. I have reviewed this Amendment to the Annual Report on Form 10-K/A of Juniper Pharmaceuticals, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

 

/s/ Jeffrey E. Young 

Jeffrey E. Young

Senior Vice President, Finance, Chief Financial Officer and Treasurer

(Principal Financial and Accounting Officer)

DATE: May 1, 2017